ACVR1 and fibrodysplasia ossificans progressiva: Activity of mutant ACVR1 still requires ligand-mediated activation of type II receptors and does not seem to be tumorigenic alone, since the same ACVR1-activating mutations found in hereditary fibrodysplasia ossificans progressiva (FOP) do not result in cancer predisposition93,94.